The impact of GnRH-agonist triggers on autologous in vitro fertilization outcomes: A retrospective analysis

 

Show simple item record

dc.contributor.advisor Matjila, M
dc.contributor.advisor Le Roux, P
dc.contributor.author Oosthuizen, Lizle
dc.date.accessioned 2021-09-15T16:28:36Z
dc.date.available 2021-09-15T16:28:36Z
dc.date.issued 2020_
dc.identifier.citation Oosthuizen, L. 2020. The impact of GnRH-agonist triggers on autologous in vitro fertilization outcomes: A retrospective analysis. . ,Faculty of Health Sciences ,Department of Obstetrics and Gynaecology. http://hdl.handle.net/11427/33934 en_ZA
dc.identifier.uri http://hdl.handle.net/11427/33934
dc.description.abstract BACKGROUND: In vitro fertilization in assisted reproduction requires controlled ovarian stimulation with exogenous gonadotrophins and oocyte maturation before ultrasound guided aspiration. GnRH-agonists have been utilized as an alternative to hCG for oocyte maturation prior to follicle aspiration. GnRH-agonist triggers are proven to lower ovarian hyperstimulation syndrome risk, a condition that can be life threatening. Lower pregnancy rates have been reported in the literature with the GnRH-agonist trigger, leading to recommendations of elective embryo cryopreservation, delayed transfer and increased costs to the patient. AIM: To determine if intensive luteal phase support of GnRH-agonist triggered cycles with intramuscular progesterone and oral oestrogen can result in similar pregnancy rates when comparing fresh embryo transfer outcomes with those of hCG triggered cycles. STUDY DESIGN, SIZE, DURATION: The study was a retrospective analysis of 279 fresh embryo transfers in autologous IVF cycles, which took place over the period of one year at Cape Fertility Clinic in Cape Town. RESULTS: Biochemical (49.40% vs 41.84%), clinical (43.37% vs 36.22%) and ongoing pregnancy rates (37.35% vs 33.16%) were higher in the GnRH-agonist triggered arm in comparison to the hCG triggered arm, respectively. Miscarriage rates were similar at 24.29% in the GnRH-agonist arm, versus 20.73% in the hCG triggered arm. None of the results were statistically significant. CONCLUSION: Similar pregnancy rates can be achieved with both hCG and GnRH-agonist triggered IVF cycles by supporting the GnRH-agonist triggered luteal phase with intensive intramuscular progesterone support.
dc.subject Obstetrics and Gynaecology
dc.title The impact of GnRH-agonist triggers on autologous in vitro fertilization outcomes: A retrospective analysis
dc.type Master Thesis
dc.date.updated 2021-09-15T01:48:39Z
dc.language.rfc3066 eng
dc.publisher.faculty Faculty of Health Sciences
dc.publisher.department Department of Obstetrics and Gynaecology
dc.type.qualificationlevel Masters
dc.type.qualificationlevel MPhil
dc.identifier.apacitation Oosthuizen, L. (2020). <i>The impact of GnRH-agonist triggers on autologous in vitro fertilization outcomes: A retrospective analysis</i>. (). ,Faculty of Health Sciences ,Department of Obstetrics and Gynaecology. Retrieved from http://hdl.handle.net/11427/33934 en_ZA
dc.identifier.chicagocitation Oosthuizen, Lizle. <i>"The impact of GnRH-agonist triggers on autologous in vitro fertilization outcomes: A retrospective analysis."</i> ., ,Faculty of Health Sciences ,Department of Obstetrics and Gynaecology, 2020. http://hdl.handle.net/11427/33934 en_ZA
dc.identifier.vancouvercitation Oosthuizen L. The impact of GnRH-agonist triggers on autologous in vitro fertilization outcomes: A retrospective analysis. []. ,Faculty of Health Sciences ,Department of Obstetrics and Gynaecology, 2020 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/33934 en_ZA
dc.identifier.ris TY - Master Thesis AU - Oosthuizen, Lizle AB - BACKGROUND: In vitro fertilization in assisted reproduction requires controlled ovarian stimulation with exogenous gonadotrophins and oocyte maturation before ultrasound guided aspiration. GnRH-agonists have been utilized as an alternative to hCG for oocyte maturation prior to follicle aspiration. GnRH-agonist triggers are proven to lower ovarian hyperstimulation syndrome risk, a condition that can be life threatening. Lower pregnancy rates have been reported in the literature with the GnRH-agonist trigger, leading to recommendations of elective embryo cryopreservation, delayed transfer and increased costs to the patient. AIM: To determine if intensive luteal phase support of GnRH-agonist triggered cycles with intramuscular progesterone and oral oestrogen can result in similar pregnancy rates when comparing fresh embryo transfer outcomes with those of hCG triggered cycles. STUDY DESIGN, SIZE, DURATION: The study was a retrospective analysis of 279 fresh embryo transfers in autologous IVF cycles, which took place over the period of one year at Cape Fertility Clinic in Cape Town. RESULTS: Biochemical (49.40% vs 41.84%), clinical (43.37% vs 36.22%) and ongoing pregnancy rates (37.35% vs 33.16%) were higher in the GnRH-agonist triggered arm in comparison to the hCG triggered arm, respectively. Miscarriage rates were similar at 24.29% in the GnRH-agonist arm, versus 20.73% in the hCG triggered arm. None of the results were statistically significant. CONCLUSION: Similar pregnancy rates can be achieved with both hCG and GnRH-agonist triggered IVF cycles by supporting the GnRH-agonist triggered luteal phase with intensive intramuscular progesterone support. DA - 2020_ DB - OpenUCT DP - University of Cape Town KW - Obstetrics and Gynaecology LK - https://open.uct.ac.za PY - 2020 T1 - The impact of GnRH-agonist triggers on autologous in vitro fertilization outcomes: A retrospective analysis TI - The impact of GnRH-agonist triggers on autologous in vitro fertilization outcomes: A retrospective analysis UR - http://hdl.handle.net/11427/33934 ER - en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record